N-Fmoc-cyclohexyl-L-homoalanine is a non-natural, protected amino acid derivative. Its structure features a cyclohexyl side chain attached to the beta-carbon (homoalanine backbone) and an N-terminal Fmoc (9-fluorenylmethoxycarbonyl) protecting group. This specific side chain imparts significant hydrophobicity and conformational constraints to the molecule. This compound is primarily employed as a specialized building block in solid-phase peptide synthesis (SPPS). The Fmoc group is readily cleaved under mild basic conditions, allowing for the sequential elongation of peptide chains. The incorporation of the cyclohexyl-L-homoalanine residue is designed to modulate the peptide's properties, such as enhancing metabolic stability, altering secondary structure propensity (e.g., promoting beta-turn or helical conformations), and improving binding affinity or selectivity in peptide-based drug discovery. It is a key reagent for synthesizing peptides with tailored biological activities and improved pharmacokinetic profiles. As a protected amino acid, it falls under the category of peptide synthesis reagents. Its defined structure and specific application in constructing bioactive sequences distinguish it from generic amine building blocks, placing its primary utility in life science research and pharmaceutical development.